Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Smoldering Disease Detection

Smoldering Disease Burden

BTK Enzyme

EoETaly Guidelines Part-1

Tolebrutinib Direct Effects on Myeloid Cells in PwMS

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

EoE Pathophysiology

VESTIGE Trial Results: Dupilumab in Type 2 Asthma

This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.

New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention

Loss of Smell Improvement in Patients With CRSwNP